Goldman Sachs Group Inc. Has $100.14 Million Position in HealthEquity, Inc. $HQY

Key Points

• Goldman Sachs Group Inc. increased its position in HealthEquity, owning approximately 1.31% of the company's stock, valued at over $100 million as of the latest SEC filing.
• HealthEquity's shares have received positive ratings from analysts, with target prices raised by firms like JPMorgan and Goldman Sachs, indicating strong investor confidence.
• Institutional investors dominate ownership of HealthEquity, holding over 99.55% of its stock, reflecting significant backing from major financial entities.

Goldman Sachs Group Inc. raised its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 1.4% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,133,166 shares of the company's stock after acquiring an additional 15,458 shares during the quarter. Goldman Sachs Group Inc. owned approximately 1.31% of HealthEquity worth $100,138,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in HQY. Versant Capital Management Inc acquired a new stake in HealthEquity in the first quarter valued at $28,000. WPG Advisers LLC acquired a new stake in HealthEquity in the first quarter valued at $28,000. Northwestern Mutual Wealth Management Co. lifted its stake in HealthEquity by 176.4% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock valued at $58,000 after acquiring an additional 418 shares during the last quarter. Larson Financial Group LLC lifted its stake in HealthEquity by 1,366.0% in the first quarter. Larson Financial Group LLC now owns 689 shares of the company's stock valued at $61,000 after acquiring an additional 642 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S acquired a new stake in HealthEquity in the first quarter valued at $65,000. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Buying and Selling

In related news, EVP Michael Henry Fiore sold 1,794 shares of the firm's stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the transaction, the executive vice president directly owned 53,225 shares of the company's stock, valued at approximately $5,414,579.25. This trade represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.50% of the company's stock.

Analysts Set New Price Targets

A number of research firms have recently issued reports on HQY. JPMorgan Chase & Co. raised their target price on shares of HealthEquity from $125.00 to $126.00 and gave the stock an "overweight" rating in a research note on Wednesday, September 3rd. The Goldman Sachs Group raised their target price on shares of HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 4th. Barrington Research restated an "outperform" rating and set a $125.00 target price on shares of HealthEquity in a research note on Friday, August 29th. Raymond James Financial restated a "strong-buy" rating and set a $120.00 target price (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Finally, Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research note on Friday, June 6th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, HealthEquity has an average rating of "Buy" and an average target price of $119.77.

HealthEquity Price Performance

NASDAQ:HQY opened at $92.49 on Friday. HealthEquity, Inc. has a 52 week low of $74.07 and a 52 week high of $116.65. The firm has a market cap of $7.97 billion, a price-to-earnings ratio of 56.05, a P/E/G ratio of 1.32 and a beta of 0.50. The firm's 50-day simple moving average is $93.46 and its 200 day simple moving average is $94.50. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.